HealthEquity, Inc. (HQY)
NASDAQ: HQY · IEX Real-Time Price · USD
85.76
-0.86 (-0.99%)
At close: Jul 2, 2024, 4:00 PM
85.58
-0.18 (-0.21%)
After-hours: Jul 2, 2024, 7:45 PM EDT
HealthEquity Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for HealthEquity stock have an average target of 101.45, with a low estimate of 72 and a high estimate of 110. The average target predicts an increase of 18.30% from the current stock price of 85.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HealthEquity stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 3 | 3 | 3 | 3 |
| Buy | 6 | 6 | 7 | 8 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $107 → $110 | Buy | Maintains | $107 → $110 | +28.26% | Jun 20, 2024 |
| Raymond James | Raymond James | Buy Maintains $100 → $105 | Buy | Maintains | $100 → $105 | +22.43% | Jun 7, 2024 |
| Keybanc | Keybanc | Buy Maintains $95 → $100 | Buy | Maintains | $95 → $100 | +16.60% | Jun 5, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $105 → $107 | Buy | Maintains | $105 → $107 | +24.77% | Jun 4, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $100 → $105 | Buy | Maintains | $100 → $105 | +22.43% | Jun 4, 2024 |
Financial Forecast
Revenue This Year
1.18B
from 999.59M
Increased by 18.35%
Revenue Next Year
1.34B
from 1.18B
Increased by 13.44%
EPS This Year
3.04
from 0.64
Increased by 374.42%
EPS Next Year
3.73
from 3.04
Increased by 22.75%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.2B | 1.5B | 1.6B |
| Avg | 1.2B | 1.3B | 1.5B |
| Low | 1.1B | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 23.8% | 23.8% | 22.1% |
| Avg | 18.3% | 13.4% | 11.9% |
| Low | 14.1% | 7.7% | 6.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.26 | 4.22 | 5.28 |
| Avg | 3.04 | 3.73 | 4.71 |
| Low | 2.89 | 3.32 | 4.30 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 408.6% | 39.0% | 41.7% |
| Avg | 374.4% | 22.7% | 26.4% |
| Low | 351.7% | 9.4% | 15.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.